ResourceDrug Discovery & Development
NanoDrop Ultra Acclaro Pro performance data
9 Dec 2025Biopharmaceutical production often yields highly concentrated samples, making serial dilutions common and time‑consuming. The Thermo Scientific™ NanoDrop™ Ultra instruments, with optional Acclaro™ Pro software, deliver ±5% accuracy for concentrated biomolecules in under 30 seconds, without dilutions or consumables. Discover how precise protein and nucleic acid quantification supports reliable quality control and efficient workflows.
Related products
Request Quote for All Products
NanoDrop Ultra
Thermo Fisher ScientificNanoDrop Ultra is a microvolume UV-Vis spectrophotometer that provides high-accuracy absorbance measurements for DNA, RNA, and proteins. It features advanced software for detecting impurities and differentiating nucleic acids from diverse biological samples, ensuring precise analytical results.
Links
Tags
DNA / RNA QuantificationDetection and quantification of nucleic acids is important in molecular biology, cloning, expression, forensics and clinical diagnostics. Nucleic acids can be detected by labeling with colorimetric, fluorescent or radio labels and using in situ hybridization kits to identify specific sequences. Multiple nucleic acids can be detected and quantified at once using RNA / DNA detection beads or RNA / DNA microarrays. Find the best DNA / RNA Quantification products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Software PlatformsSoftware platforms are useful for various stages of laboratory experiments from data collection to data storage and processing. For instance lab software is available for system control, data management, data analysis and qualification / validation.BiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.